Enlivex Therapeutics Ltd. (FRA:1BT)
Germany · Delayed Price · Currency is EUR 0.8250
+0.0250 (3.12%)
At close: Nov 28, 2025
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of €19.02 million as of December 1, 2025. Its market cap has decreased by -23.19% in one year.
Market Cap
19.02M
Enterprise Value
3.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.83
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 90.03M to 19.02M, a decrease of -78.87%. That is a compound annual growth rate of -20.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 20.32M | -18.23% |
| Dec 31, 2024 | 24.85M | -45.30% |
| Dec 29, 2023 | 45.43M | -33.03% |
| Dec 30, 2022 | 67.83M | -32.66% |
| Dec 31, 2021 | 100.74M | 1.56% |
| Dec 31, 2020 | 99.19M | 28.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |